Portage Biotech Management
Management criteria checks 2/4
Portage Biotech's CEO is Ian Walters, appointed in May 2019, has a tenure of 7.75 years. total yearly compensation is $1.72M, comprised of 36.4% salary and 63.6% bonuses, including company stock and options. directly owns 1.53% of the company’s shares, worth $88.33K. The average tenure of the management team and the board of directors is 4 years and 2.3 years respectively.
Key information
Ian Walters
Chief executive officer
US$1.7m
Total compensation
| CEO salary percentage | 36.4% |
| CEO tenure | 5yrs |
| CEO ownership | 1.5% |
| Management average tenure | 4yrs |
| Board average tenure | 2.3yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$145m |
| Sep 30 2023 | n/a | n/a | -US$113m |
| Jun 30 2023 | n/a | n/a | -US$109m |
| Mar 31 2023 | US$2m | US$624k | -US$105m |
| Dec 31 2022 | n/a | n/a | -US$17m |
| Sep 30 2022 | n/a | n/a | -US$14m |
| Jun 30 2022 | n/a | n/a | -US$16m |
| Mar 31 2022 | US$3m | US$459k | -US$17m |
| Dec 31 2021 | n/a | n/a | -US$21m |
| Sep 30 2021 | n/a | n/a | -US$19m |
| Jun 30 2021 | n/a | n/a | -US$18m |
| Mar 31 2021 | US$6m | US$369k | -US$16m |
| Dec 31 2020 | n/a | n/a | -US$6m |
| Sep 30 2020 | n/a | n/a | -US$6m |
| Jun 30 2020 | n/a | n/a | -US$5m |
| Mar 31 2020 | US$350k | US$350k | -US$5m |
| Dec 31 2019 | n/a | n/a | -US$6m |
| Sep 30 2019 | n/a | n/a | -US$5m |
| Jun 30 2019 | n/a | n/a | -US$4m |
| Mar 31 2019 | US$202k | n/a | -US$3m |
| Dec 31 2018 | n/a | n/a | US$124m |
| Sep 30 2018 | n/a | n/a | US$124m |
| Jun 30 2018 | n/a | n/a | US$124m |
| Mar 31 2018 | US$99k | n/a | US$124m |
Compensation vs Market: Ian's total compensation ($USD1.72M) is above average for companies of similar size in the US market ($USD663.50K).
Compensation vs Earnings: Ian's compensation has been consistent with company performance over the past year.
CEO
Ian Walters (55 yo)
5yrs
Tenure
US$1,715,837
Compensation
Dr. Ian B. Walters, M.D. M.B.A. has been Chairman of the Board at Portage Biotech Inc. since August 2022. He has been the Chief Executive Officer of Portage Biotech Inc. since May 1, 2019 and has been its...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman of Board | 5yrs | US$1.72m | 1.53% $ 88.3k | |
| Chief Financial Officer | 4yrs | US$873.39k | no data | |
| Chief Scientific Officer | 5.3yrs | US$447.61k | 0.71% $ 41.1k | |
| Chief Business Officer | 2.3yrs | US$339.03k | no data | |
| Vice President of Development | no data | US$828.46k | no data | |
| Chief Accounting Officer | 2.3yrs | no data | no data |
4.0yrs
Average Tenure
55yo
Average Age
Experienced Management: PRTG's management team is considered experienced (4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman of Board | 7.8yrs | US$1.72m | 1.53% $ 88.3k | |
| Independent Lead Director | 10.9yrs | US$103.98k | 17.2% $ 993.1k | |
| Independent Director | 1.8yrs | US$198.74k | 0.12% $ 6.9k | |
| Independent Director | 8.1yrs | US$96.48k | 0.37% $ 21.2k | |
| Independent Director | 2.3yrs | US$86.98k | 14.81% $ 855.5k | |
| Independent Director | 2.3yrs | US$90.98k | no data | |
| Independent Director | 2.3yrs | US$91.48k | no data |
2.3yrs
Average Tenure
61yo
Average Age
Experienced Board: PRTG's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.